Structure Therapeutics Inc. (GPCR) stock
GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.17−0.40 (-2.15%)
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
Structure Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Structure Therapeutics's total assets was $1.43B at Jun 30, 2026. For fiscal 2025 it was $1.58B, up 75.3% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58B | +75.3% |
| FY2024 | Dec 31, 2024 | $903.33M | +87.4% |
| FY2023 | Dec 31, 2023 | $482.02M | +392.6% |
| FY2022 | Dec 31, 2022 | $97.85M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.43B | +74.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.51B | +74.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.58B | +75.3% |
| Q3 FY2025 | Sep 30, 2025 | $832.16M | -10.8% |
| Q2 FY2025 | Jun 30, 2025 | $816.44M | -13.8% |
| Q1 FY2025 | Mar 31, 2025 | $866.55M | +89.5% |
| Q4 FY2024 | Dec 31, 2024 | $903.33M | +87.4% |
| Q3 FY2024 | Sep 30, 2024 | $933.22M | +331.3% |
| Q2 FY2024 | Jun 30, 2024 | $947.03M | +312.8% |
| Q1 FY2024 | Mar 31, 2024 | $457.23M | +84.8% |
| Q4 FY2023 | Dec 31, 2023 | $482.02M | +392.6% |
| Q3 FY2023 | Sep 30, 2023 | $216.37M | – |
| Q2 FY2023 | Jun 30, 2023 | $229.43M | – |
| Q1 FY2023 | Mar 31, 2023 | $247.35M | – |
| Q4 FY2022 | Dec 31, 2022 | $97.85M | – |
See a number that looks wrong?